Clover Health Investments Corp

Clover Health Investments Corp(CLOV)股票分析

$4.630

+0.071 (+1.54%)收盘时

Loading chart…
最高
4.640
开盘
4.590
成交量加权均价
4.60
成交量
3.05M
市值
645.37M
最低
4.530
成交额
14.02M
企业价值/息税折旧摊销前利润(TTM)
16.65

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states.

AI 分析 of Clover Health Investments Corp (CLOV)

买入

Clover Health Investments Corp is a good buy right now, trading at $4.60 with a forward P/E of 37.74, indicating growth potential. The stock has shown a remarkable YTD change of +90.87%, reflecting strong investor interest and performance. Additionally, the company has recently earned top honors in Medicare Advantage ratings, which could enhance its market position. The main risk is the negative EPS estimate of -0.01 for the upcoming earnings report on November 4, 2026, which could impact short-term sentiment.

估值指标

Clover Health Investments Corp(CLOV)当前预期市盈率为 37.74,5 年平均预期市盈率为 3.76。

预期市盈率

合理
5 年均值 P/E
3.76
当前P/E
37.74
高估
41.07
低估
-33.55

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
11.13
当前EV/EBITDA
16.65
高估
30.17
低估
-7.90

预期市销率

合理
5 年均值 P/S
0.54
当前P/S
0.69
高估
0.87
低估
0.22

Alphio AI 对 CLOV 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%CLOV

$3.66

情景价格

基

基准

基准 · 50%CLOV

$3.60

情景价格

悲

悲观

悲观 · 25%CLOV

$3.51

情景价格

持有 CLOV 的大户

G

GMT Capital Corp.

+ 持有CLOV

-1.07%

3个月收益率

事件时间线

2026-10-08 (ET)

20:00:00

Nasdaq Composite Falls 1.3% as Tech Stocks Struggle

2026-09-10 (ET)

16:30:00

Major Averages Close Broadly Lower as Oil Surpasses $100

12:30:00

Major Averages Broadly Lower as Oil Surpasses $100

12:30:00

Clover Health Shares Rise 9.1% to $4.74

资讯

CLOV 常见问题 —— 由 Alphio AI 解答

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Clover Health Investments Corp is a good buy right now, trading at $4.60 with a forward P/E of 37.74, indicating growth potential. The stock has shown a remarkable YTD change of +90.87%, reflecting strong investor interest and performance. Additionally, the company has recently earned top honors in Medicare Advantage ratings, which could enhance its market position. The main risk is the negative EPS estimate of -0.01 for the upcoming earnings report on November 4, 2026, which could impact short-term sentiment.

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易